A Study for the Assessment of the Words Used by Patients and Physicians to Express Asthma Symptoms
A Cross Sectional Study for the Assessment of the Words Used by Patients and Physicians to Express Asthma Symptoms and the Limitations of Daily Activities in Primary Care. The " Asthma Language " Survey
1 other identifier
observational
696
1 country
40
Brief Summary
The purpose of the study is to evaluate the concordance of the most frequently used words by the patients and the physicians to express asthma symptoms and the limitations of daily activities caused by asthma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2009
Shorter than P25 for all trials
40 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2009
CompletedFirst Submitted
Initial submission to the registry
September 22, 2009
CompletedFirst Posted
Study publicly available on registry
September 29, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedDecember 17, 2009
December 1, 2009
September 22, 2009
December 16, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The concordance of the most frequently used words by the patients and the physicians to express asthma symptoms and the limitations of daily activities caused by asthma
Day 1
Secondary Outcomes (3)
The most frequently used words (lexical intensity) by the patient and the physician to express asthma symptoms and the limitations of daily activities.
Day 1
The concordance of words used by physicians and patients according to the level of asthma control (as assessed by ACQ).
Day 1
The actions recommended by the physician or those initiated by the patient and are associated with words that express symptoms.
Day 1
Study Arms (1)
Asthma Language between patients and physicians
Eligibility Criteria
Primary care patients with persistent asthma treated with inhaled corticosteroid-based maintenance treatment for at least 6 months and followed up by thep hysician for at least the same period of time.
You may qualify if:
- Diagnosis of persistent asthma treated with inhaled corticosteroid-based maintenance treatment for at least 6 months and followed up by the investigator for at least the same period of time
You may not qualify if:
- Patient with a cardiac disease (congestive heart failure, coronary heart disease)
- Patient with a respiratory disease other than asthma (COPD, sleep apnoea syndrome)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (40)
Research Site
Pátrai, Achaia, Greece
Research Site
Agrinio, Aitoloakarnanias, Greece
Research Site
Thérmo, Aitoloakarnanias, Greece
Research Site
Naupaktos, Aitoloakarnania, Greece
Research Site
Argos, Argolida, Greece
Research Site
Arta, Artas, Greece
Research Site
Athens, Attica, Greece
Research Site
Peraious, Attica, Greece
Research Site
Livadia, Biotias, Greece
Research Site
Chalcis, Chalkida, Greece
Research Site
Chalkidiki, Chalkidiki, Greece
Research Site
Chania, Crete, Greece
Research Site
Heraklion, Crete, Greece
Research Site
Rethymno, Crete, Greece
Research Site
Ermoupoli, Cyclades, Greece
Research Site
Rhodes, Dodekanisou, Greece
Research Site
Drama, Drammas, Greece
Research Site
Kastoria, Florinas, Greece
Research Site
Amfisa, Fokidos, Greece
Research Site
Pírgos, Ilia, Greece
Research Site
Véroia, Imathia, Greece
Research Site
Ioannina, Ioanninon, Greece
Research Site
Karditsa, Karditsis, Greece
Research Site
Chrisoupoli, Kavalas, Greece
Research Site
Kavala, Kavalas, Greece
Research Site
Loutraki, Korinthia, Greece
Research Site
Ptolemaida, Kozani, Greece
Research Site
Ksanthi, Ksanthis, Greece
Research Site
Lakonia, Lakonia, Greece
Research Site
Larissa, Larisas, Greece
Research Site
Farsala, Larrisa, Greece
Research Site
Volos, Magnisia, Greece
Research Site
Kalamata, Messinia, Greece
Research Site
Katerini, Peierias, Greece
Research Site
Edessa, Pella, Greece
Research Site
Komotini, Rodopi, Greece
Research Site
Serres, Serron, Greece
Research Site
Igoumenitsa, Thesprotia, Greece
Research Site
Thessaloniki, Thessalonikis, Greece
Research Site
Trikala, Trikalon, Greece
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mina Gaga, MD
Director of the 7th Respiratory Clinic, Sotiria Hospital, Athens, Greece
- STUDY DIRECTOR
Panagiotis Pontikis, Dr.
Marketing Company Medical Director, AstraZeneca Greece
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
September 22, 2009
First Posted
September 29, 2009
Study Start
September 1, 2009
Study Completion
December 1, 2009
Last Updated
December 17, 2009
Record last verified: 2009-12